Penny Lympany

1.3k total citations
27 papers, 1.0k citations indexed

About

Penny Lympany is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Rheumatology. According to data from OpenAlex, Penny Lympany has authored 27 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 8 papers in Rheumatology. Recurrent topics in Penny Lympany's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Penny Lympany is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers), Sarcoidosis and Beryllium Toxicity Research (6 papers) and Eosinophilic Disorders and Syndromes (4 papers). Penny Lympany collaborates with scholars based in United Kingdom, United States and Italy. Penny Lympany's co-authors include R M du Bois, Ken I. Welsh, D.M. Kemeny, Robin J. McAnulty, P K Jeffery, Robina K Coker, Laurent Guy, Shahriar Shahzeidi, R M du Bois and Lisa A. Maier and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Penny Lympany

27 papers receiving 1.0k citations

Peers

Penny Lympany
Richárd Márkus United States
Edward B. Blau United States
J J Weening Netherlands
Allan Sturgess Australia
Susan Mathai United States
Matthew J. Olnes United States
Richárd Márkus United States
Penny Lympany
Citations per year, relative to Penny Lympany Penny Lympany (= 1×) peers Richárd Márkus

Countries citing papers authored by Penny Lympany

Since Specialization
Citations

This map shows the geographic impact of Penny Lympany's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Penny Lympany with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Penny Lympany more than expected).

Fields of papers citing papers by Penny Lympany

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Penny Lympany. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Penny Lympany. The network helps show where Penny Lympany may publish in the future.

Co-authorship network of co-authors of Penny Lympany

This figure shows the co-authorship network connecting the top 25 collaborators of Penny Lympany. A scholar is included among the top collaborators of Penny Lympany based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Penny Lympany. Penny Lympany is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mrázek, František, Penny Lympany, Anna L. Lagan, et al.. (2008). The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens. 72(5). 483–486. 4 indexed citations
2.
Sato, Hiroe, Lori Silveira, Tasha E. Fingerlin, et al.. (2007). TNF polymorphism and bronchoalveolar lavage cell TNF-α levels in chronic beryllium disease and beryllium sensitization. Journal of Allergy and Clinical Immunology. 119(3). 687–696. 18 indexed citations
3.
Yeo, Tun Kuan, Muhammad A. Ahad, Paolo Spagnolo, et al.. (2006). Chemokine gene polymorphisms in idiopathic anterior uveitis. Cytokine. 35(1-2). 29–35. 20 indexed citations
4.
Patel, Ashok, William R. Scott, Penny Lympany, et al.. (2004). The TGF‐β1 gene codon 10 polymorphism contributes to the genetic predisposition to nephropathy in Type 1 diabetes. Diabetic Medicine. 22(1). 69–73. 31 indexed citations
5.
Lee, Eunwoo, et al.. (2004). Transforming growth factor‐β1 polymorphisms in Korean patients with systemic sclerosis. Tissue Antigens. 63(5). 491–495. 18 indexed citations
6.
Maier, Lisa A., Hiroe Sato, Penny Lympany, et al.. (2003). Influence of MHC CLASS II in Susceptibility to Beryllium Sensitization and Chronic Beryllium Disease. The Journal of Immunology. 171(12). 6910–6918. 93 indexed citations
7.
Maier, Lisa A., John W. Martyny, Margaret M. Mroz, et al.. (2002). Genetic and Environmental Risk Factors in Beryllium Sensitization and Chronic Beryllium Disease. CHEST Journal. 121(3). 81S–81S. 14 indexed citations
8.
Maier, Lisa A., Richard T. Sawyer, Penny Lympany, et al.. (2001). High Beryllium-stimulated TNF- α Is Associated with the − 308 TNF- α Promoter Polymorphism and with Clinical Severity in Chronic Beryllium Disease. American Journal of Respiratory and Critical Care Medicine. 164(7). 1192–1199. 43 indexed citations
9.
Schürmann, Manfred, Penny Lympany, Bertram Müller‐Myhsok, et al.. (2000). Familial Sarcoidosis is Linked to the Major Histocompatibility Complex Region. American Journal of Respiratory and Critical Care Medicine. 162(3). 861–864. 85 indexed citations
10.
Renzoni, Elisabetta, Penny Lympany, Piersante Sestini, et al.. (2000). Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthritis & Rheumatism. 43(7). 1633–1633. 4 indexed citations
11.
Taylor, A J Newman, Paul Cullinan, Penny Lympany, et al.. (1999). Interaction of HLA Phenotype and Exposure Intensity in Sensitization to Complex Platinum Salts. American Journal of Respiratory and Critical Care Medicine. 160(2). 435–438. 58 indexed citations
12.
Lympany, Penny, AM Southcott, Ken I. Welsh, et al.. (1999). T‐cell receptor gene usage in patients with fibrosing alveolitis and control subjects. European Journal of Clinical Investigation. 29(2). 173–181. 10 indexed citations
13.
Lympany, Penny, et al.. (1999). Polymorphic analysis of the high‐affinity tumor necrosis factor receptor 2. Tissue Antigens. 54(6). 585–591. 25 indexed citations
15.
Coker, Robina K, Laurent Guy, Shahriar Shahzeidi, et al.. (1997). Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosis.. PubMed. 150(3). 981–91. 223 indexed citations
16.
Lympany, Penny, Martin Petřek, AM Southcott, et al.. (1996). HLA‐DPB POLYMORPHISMS: Glu 69 ASSOCIATION WITH SARCOIDOSIS. International Journal of Immunogenetics. 23(5). 353–359. 44 indexed citations
17.
Lympany, Penny, Ken I. Welsh, Pandora E. Christie, et al.. (1993). An analysis with sequence-specific oligonucleotide probes of the association between aspirin-induced asthma and antigens of the HLA system. Journal of Allergy and Clinical Immunology. 92(1). 114–123. 35 indexed citations
18.
Lympany, Penny, et al.. (1992). Genetic analysis using DNA polymorphism of the linkage between chromosome 11q13 and atopy and bronchial hyperresponsiveness to methacholine. Journal of Allergy and Clinical Immunology. 89(2). 619–628. 53 indexed citations
19.
Lympany, Penny, et al.. (1992). Genetic analysis of the linkage between chromosome 11q and atopy. Clinical & Experimental Allergy. 22(12). 1085–1092. 48 indexed citations
20.
Lympany, Penny, et al.. (1990). An HLA-associated nonresponsiveness to melittin: A components of bee venom. Journal of Allergy and Clinical Immunology. 86(2). 160–170. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026